Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Skye Bioscience Inc (SKYE)

Skye Bioscience Inc (SKYE)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.4300 +0.0300 (+2.14%) 04/02/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.4593 +0.0293 (+2.05%) 17:58 ET
Quote Overview for Wed, Apr 2nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.4100
Day High
1.4400
Open 1.4100
Previous Close 1.4000 1.4000
Volume 103,300 103,300
Avg Vol 220,250 220,250
Stochastic %K 3.13% 3.13%
Weighted Alpha -80.74 -80.74
5-Day Change -0.8700 (-37.83%) -0.8700 (-37.83%)
52-Week Range 1.3700 - 17.6473 1.3700 - 17.6473
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,365
  • Shares Outstanding, K 30,975
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,570 K
  • EBIT $ -30 M
  • EBITDA $ -29 M
  • 60-Month Beta 1.88
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.71

Options Overview Details

View History
  • Implied Volatility 306.92% ( +31.44%)
  • Historical Volatility 116.18%
  • IV Percentile 54%
  • IV Rank 38.56%
  • IV High 783.06% on 12/20/24
  • IV Low 8.06% on 09/16/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 1,171
  • Open Int (30-Day) 1,402

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.31
  • Number of Estimates 2
  • High Estimate -0.26
  • Low Estimate -0.35
  • Prior Year -0.18
  • Growth Rate Est. (year over year) -72.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3700 +4.38%
on 04/01/25
Period Open: 2.8500
2.9200 -51.03%
on 03/03/25
-1.4200 (-49.82%)
since 02/28/25
3-Month
1.3700 +4.38%
on 04/01/25
Period Open: 2.8500
4.2500 -66.35%
on 01/31/25
-1.4200 (-49.82%)
since 01/02/25
52-Week
1.3700 +4.38%
on 04/01/25
Period Open: 14.1000
17.6473 -91.90%
on 04/18/24
-12.6700 (-89.86%)
since 04/02/24

Most Recent Stories

More News
Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

SKYE : 1.4300 (+2.14%)
Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025

SKYE : 1.4300 (+2.14%)
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SKYE : 1.4300 (+2.14%)
Is This Penny Stock’s 525% Upside Potential an Attainable Goal?

Skye Bioscience is trying to establish a presence in the weight-loss drug market.

SKYE : 1.4300 (+2.14%)
NVO : 68.24 (+0.31%)
$SPX : 5,670.97 (+0.67%)
LLY : 818.22 (+1.61%)
Skye Bioscience to Participate in SXSW Session on Obesity

SKYE : 1.4300 (+2.14%)
Skye Bioscience to Present at TD Cowen Health Care Conference

SKYE : 1.4300 (+2.14%)
Skye Bioscience Announces Participation in February Conferences

SKYE : 1.4300 (+2.14%)
Skye Bioscience Provides 2025 Look Ahead and Year in Review

SKYE : 1.4300 (+2.14%)
Skye Bioscience to Present Corporate Overview at 43rd Annual J.P. Morgan Healthcare Conference

Skye Bioscience will present its corporate overview and Phase 2 trial results at the J.P. Morgan Healthcare conference.Quiver AI SummarySkye Bioscience, Inc. announced that it will present a corporate...

SKYE : 1.4300 (+2.14%)
Skye Bioscience to Present at J.P. Morgan Healthcare Conference

SKYE : 1.4300 (+2.14%)

Business Summary

Skye Bioscience Inc. is a biopharmaceutical company. It is focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need. Skye Bioscience Inc., formerly known as Emerald Bioscience Inc., is based in San Diego, Calif.

See More

Key Turning Points

3rd Resistance Point 1.4733
2nd Resistance Point 1.4567
1st Resistance Point 1.4433
Last Price 1.4300
1st Support Level 1.4133
2nd Support Level 1.3967
3rd Support Level 1.3833

See More

52-Week High 17.6473
Fibonacci 61.8% 11.4294
Fibonacci 50% 9.5087
Fibonacci 38.2% 7.5879
Last Price 1.4300
52-Week Low 1.3700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades